Filing Flows › Lexicon Pharmaceuticals (LXRX) › Q2 2026 › vs Q1 2026
Lexicon Pharmaceuticals (LXRX) Q2 2026 vs Q1 2026 (quarter over quarter)
Lexicon Pharmaceuticals's revenue fell $20.4M (-97%) from $21.1M in Q1 2026 to $692K in Q2 2026.
Lexicon Pharmaceuticals, Q2 2026: revenue $692K (-98% year over year), net loss $31.8M, operating cash flow −$9.2M. The chart draws each line against Q1 2026, the increases inside each band.
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $692K | $21.1M | −$20.4M | -97% |
| Net loss | $31.8M | $1.0M | $30.7M | 30× |
| Costs & expenses | $32.5M | $22.1M | $10.3M | +47% |
| Operating costs | $27.2M | $22.1M | $5.1M | +23% |
| Interest & other, net | $5.2M | $47K | $5.2M | 111× |
| Cost of revenue | $39K | $108K | −$69K | -64% |
| Research & development | $17.4M | $12.8M | $4.7M | +37% |
| SG&A | $9.8M | $9.2M | $516K | +6% |
| Operating cash sources | $31.8M | $1.0M | $30.7M | 30× |
| Depreciation & amortization | $102K | $110K | −$8K | -7% |
| Share-based compensation | $3.3M | $3.1M | $258K | +8% |
| Working capital & other | $19.1M | −$16.9M | $36.0M | — |
| Cash used in operations | $9.2M | $14.7M | −$5.5M | -38% |
| Net loss absorbed | $31.8M | $1.0M | $30.7M | 30× |
Questions
How much did Lexicon Pharmaceuticals's revenue grow quarter over quarter in Q2 2026?
Lexicon Pharmaceuticals's revenue fell $20.4M (-97%) from $21.1M in Q1 2026 to $692K in Q2 2026.